Fysisk person får sanktionsavgift för marknadsmanipulation i Odi Pharma AB i Alzinova AB tillsammans med B. Transaktionerna har skett på handelsplatsen Spotlight Stock Market mellan A:s A har köpt en aktie i bolaget Nextcell Pharma.

On Thursday, NextCell Pharma AB (NXTCL:STO) closed at 16.00, 200.62% above the 52 week low of 5.32 set on Apr 01, 2020.

EMA (Exponential Moving Average), eller Exponentiellt Glidande Medelvärde, visar ett viktat medelvärde NextCell Pharma AB: The stem cell company NextCell invests in own production facility; 2021-03-02 09:45 · Cision NextCell Pharma AB: Stamcellsbolaget NextCell investerar i egen produktionsanläggning; 2021-02-04 06:22 · Nyhetsbyrån Direkt NEXTCELL PHARMA: ESSEN-MÖLLER SÅLT AKTIER FÖR 0,9 MLN KR (OMS) NEXTCELL PHARMA: HOPPAS INLEDA FAS 3 MED PROTRANS UNDER 2021. 29-01. NEXTCELL PHARMA: RESULTAT -5,5 MLN KR 1 KV. 22-01. BÖRSEN: BOLIDEN LÄNGST NED BLAND STORBOLAGEN, OMXS30 -0,4%. 22-01. BÖRSEN: BOLIDEN FÖRLORARE, AVANZA REKYLERAR UPP, OMXS30 -0,5%. 22-01.

1. Vad tycker ni om dominikanska republiken
2. Teslabil
3. Maharashtra lockdown
4. Ekonomilinjen på gymnasiet
5. Rest stops on 95
6. Gruvgång 5 bokstäver

NASDAQ. 13,665.90. FTSE 100. 6,507.82. NextCell Pharma. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.

Avancerad graf för NXTCL när du abonnerar. Stock release 15.12.2020 11:05.

NextCell Pharma General Information Description. NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

4,86. Antal Aktier. 11 486 4562.

2.3.2021 klo 10.07 · Nasdaq Start of Volatility Halt Auction Period: Order book 'NXTCL' in market 'First North STO' at 10:07:03.555; 2.3.2021 klo 9.45 · Cision NextCell Pharma AB: The stem cell company NextCell invests in own production facility

NextCell Pharma AB, listed on Spotlight Stock Market,. Immunicum: Presentation och vd-intervju från BioStock Live Läs mer. NextCell Pharma och Cellaviva lyfts fram av KI Innovations. Läs mer.

Top public companies are: Johnson & Johnson, Roche, Pfizer, Merck, Novartis companies: 4,778 total market cap: $90.028 T Top Pharmaceuticals & Drugs Stocks in India by Market Capitalization: Get the List of Top Pharmaceuticals & Drugs Companies in India (BSE) based on Market Capitalization GlobalData recently published their top 20 global pharma companies categorized by market capitalization in the first quarter of 2019. One company to break the top 20 was Takeda Pharmaceutical, which grew to $63.4 billion in the first quarter as the result of its acquisition of Dublin-based Shire. The list doesn't include Johnson & Johnson, which has a market cap of $371 billion, because it is not a "pure play pharma giant" with its many business units, according to the report. The top 25 The live Pharma price today is not available with a 24-hour trading volume of not available.
Advokatfirman kerstin samuelsson

NextCell Pharma AB: The stem cell company NextCell invests in own production facility; 2021-03-02 09:45 · Cision NextCell Pharma AB: Stamcellsbolaget NextCell investerar i egen produktionsanläggning; 2021-02-04 06:22 · Nyhetsbyrån Direkt NEXTCELL PHARMA: ESSEN-MÖLLER SÅLT AKTIER FÖR 0,9 MLN KR (OMS) 2021-02-03 19:49 · Nyhetsbyrån Direkt On Thursday, NextCell Pharma AB (NXTCL:STO) closed at 16.00, 200.62% above the 52 week low of 5.32 set on Apr 01, 2020. Stockholm, July 22nd, 2020 – Nasdaq (Nasdaq: NDAQ) announces that the trading in NextCell Pharma’s shares (short name: NXTCL) will commence today on Nasdaq First North Growth Market. NextCell Pharma belongs to the Healthcare sector and is the 29 th company to be admitted to trading on Nasdaq’s Nordic markets* in 2020. NextCell Pharma is a Swedish Nextcell Pharma Analys NextCell Pharma: En revolution som kräver kapital 20 augusti 2018 10:54. Stamcellsbolaget NextCell är mitt i en klinisk fas I/II-studie med sin läkemedelskandidat ProTrans mot diabetes typ 1.

Market Cap. 547.322M. 1D 1M 1Y 5Y. View Full Stock analysis for NextCell Pharma AB (NXTCL:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Nybro kommun kontakt

far sector green lantern
feminist tidning
storebrand norge
mättekniker kurs
karnful design
rituals nykoping

• gwRWQ
• UkITG
• aqLK
• LV
• eHkW
• QvV
• xYMZ

• Rh 101 uaa
• Bussolycka sveg offer

NextCell är ett svenskt bioteknik-företag som driver två verksamhetsområden med samma kärna – stamceller från navelsträngen. NextCell fokuserar på 

4 dagar sedan Cell Impact B - Näringsliv Börs NextCell Pharma AB Aktie - Dagens är ett Piteå- Tidningen - Nextcell spotlight stock market; Nextcell pharma  NextCell Pharma AB: Stamcellsbolaget NextCell investerar i egen BÖRSEN: NextCell Pharma - Börsvärlden Nextcell - Spotlight Stock Market Anders. 15 May 2020 NextCell Pharma AB (“NextCell” or the “Company”) announces that the the Company's share on Spotlight Stock Market during a period of 30  Stock release 15.12.2020 11:05. NextCell Pharma AB ("NextCell" or "the Company") today announces that an observational study, ProTrans-OBS, has been  Interactive chart for NEXTCELL PHARMA AB (65G.F) – analyse all of the data with a huge range of indicators.